Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Annexin A6 | 6 | 2022 | 14 | 3.960 |
Why?
|
| Breast Neoplasms | 10 | 2017 | 1426 | 1.260 |
Why?
|
| Calcium | 5 | 2022 | 445 | 1.160 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2017 | 14 | 1.130 |
Why?
|
| Cell Line, Tumor | 16 | 2022 | 2128 | 0.990 |
Why?
|
| Exosomes | 7 | 2018 | 97 | 0.880 |
Why?
|
| Hypercalcemia | 1 | 2022 | 12 | 0.860 |
Why?
|
| Calcium Channels | 2 | 2020 | 72 | 0.790 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2020 | 2 | 0.760 |
Why?
|
| Cell Adhesion | 7 | 2020 | 209 | 0.730 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 184 | 0.680 |
Why?
|
| Signal Transduction | 8 | 2022 | 1802 | 0.590 |
Why?
|
| Blood Proteins | 3 | 2010 | 65 | 0.560 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1149 | 0.530 |
Why?
|
| Focal Adhesions | 2 | 2014 | 15 | 0.520 |
Why?
|
| Protein Kinase C | 2 | 2004 | 110 | 0.480 |
Why?
|
| Quinazolines | 1 | 2013 | 31 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 781 | 0.470 |
Why?
|
| Humans | 32 | 2023 | 34853 | 0.470 |
Why?
|
| alpha-Fetoproteins | 2 | 2022 | 29 | 0.440 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 209 | 0.430 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 287 | 0.380 |
Why?
|
| Carcinoma | 1 | 2010 | 94 | 0.370 |
Why?
|
| Cell Movement | 7 | 2020 | 545 | 0.360 |
Why?
|
| alpha-Defensins | 2 | 2021 | 15 | 0.360 |
Why?
|
| Female | 15 | 2023 | 19873 | 0.340 |
Why?
|
| Onchocerca volvulus | 2 | 1997 | 5 | 0.320 |
Why?
|
| Prognosis | 2 | 2020 | 707 | 0.320 |
Why?
|
| Parathyroid Glands | 3 | 2004 | 5 | 0.300 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 53 | 0.290 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 756 | 0.290 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 117 | 0.290 |
Why?
|
| Parathyroid Hormone | 2 | 2004 | 36 | 0.280 |
Why?
|
| Histones | 2 | 2018 | 177 | 0.270 |
Why?
|
| Carrier Proteins | 1 | 2007 | 287 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 396 | 0.240 |
Why?
|
| Hypogonadism | 1 | 2023 | 21 | 0.230 |
Why?
|
| Hydroxyurea | 1 | 2023 | 34 | 0.230 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 49 | 0.230 |
Why?
|
| Crohn Disease | 2 | 2021 | 55 | 0.230 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 13 | 0.220 |
Why?
|
| Mentors | 1 | 2023 | 111 | 0.220 |
Why?
|
| Colon | 2 | 2021 | 98 | 0.210 |
Why?
|
| Protein Precursors | 1 | 2002 | 59 | 0.210 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 63 | 0.210 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 203 | 0.210 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 122 | 0.210 |
Why?
|
| Acetylcysteine | 1 | 2002 | 58 | 0.200 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 56 | 0.200 |
Why?
|
| Oxygen | 1 | 2022 | 193 | 0.200 |
Why?
|
| Animals | 12 | 2023 | 14307 | 0.200 |
Why?
|
| Enterotoxins | 1 | 2021 | 32 | 0.200 |
Why?
|
| Glucose | 1 | 2022 | 217 | 0.200 |
Why?
|
| Organoids | 1 | 2021 | 20 | 0.200 |
Why?
|
| Phosphorylation | 2 | 2019 | 878 | 0.190 |
Why?
|
| Cell Survival | 2 | 2019 | 818 | 0.190 |
Why?
|
| Cell Nucleus | 3 | 2018 | 351 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 58 | 0.190 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 32 | 0.190 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 87 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 416 | 0.190 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 56 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 247 | 0.180 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 211 | 0.170 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 164 | 0.170 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.170 |
Why?
|
| Durapatite | 1 | 2018 | 16 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1442 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 162 | 0.160 |
Why?
|
| Mice | 5 | 2023 | 5668 | 0.160 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 74 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 180 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2021 | 1961 | 0.160 |
Why?
|
| Neoplasms | 3 | 2018 | 1033 | 0.160 |
Why?
|
| Cell Membrane | 4 | 2018 | 360 | 0.160 |
Why?
|
| Age of Onset | 1 | 2017 | 98 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 73 | 0.150 |
Why?
|
| Gene Frequency | 1 | 2017 | 155 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 102 | 0.150 |
Why?
|
| Astrocytoma | 1 | 2016 | 13 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 1997 | 24 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 859 | 0.150 |
Why?
|
| Amino Acids | 1 | 1997 | 139 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 85 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 105 | 0.140 |
Why?
|
| Antigens, Helminth | 2 | 1997 | 33 | 0.130 |
Why?
|
| Genotype | 1 | 2017 | 641 | 0.130 |
Why?
|
| Cattle | 3 | 2013 | 472 | 0.130 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2004 | 14 | 0.130 |
Why?
|
| RNA Interference | 2 | 2018 | 225 | 0.130 |
Why?
|
| Gene Expression | 2 | 2016 | 639 | 0.130 |
Why?
|
| Male | 7 | 2023 | 18870 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1056 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2018 | 294 | 0.120 |
Why?
|
| Cell Line | 3 | 2014 | 1289 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2007 | 420 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 81 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 114 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 107 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 794 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 638 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 28 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2004 | 423 | 0.120 |
Why?
|
| Lysosomes | 1 | 2013 | 80 | 0.120 |
Why?
|
| Chemotaxis | 1 | 2013 | 57 | 0.120 |
Why?
|
| Proteomics | 2 | 2021 | 302 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 73 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 133 | 0.110 |
Why?
|
| Cell Nucleus Shape | 1 | 2012 | 1 | 0.110 |
Why?
|
| Breast | 1 | 2013 | 134 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 176 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 592 | 0.100 |
Why?
|
| Onchocerca | 1 | 1990 | 4 | 0.100 |
Why?
|
| Glycerol | 1 | 2010 | 29 | 0.100 |
Why?
|
| Ions | 1 | 2010 | 61 | 0.100 |
Why?
|
| Hela Cells | 2 | 2012 | 344 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 70 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 200 | 0.090 |
Why?
|
| Endocytosis | 2 | 2020 | 104 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 183 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 143 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 173 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 2007 | 8 | 0.080 |
Why?
|
| Replication Origin | 1 | 2007 | 14 | 0.080 |
Why?
|
| G1 Phase | 1 | 2007 | 32 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2010 | 486 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 64 | 0.070 |
Why?
|
| Time Factors | 2 | 2004 | 1681 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 49 | 0.070 |
Why?
|
| DNA Helicases | 1 | 2007 | 40 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 126 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 1124 | 0.070 |
Why?
|
| Protein Binding | 2 | 2007 | 913 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1490 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 143 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 195 | 0.070 |
Why?
|
| Protein Transport | 1 | 2007 | 286 | 0.070 |
Why?
|
| Chromatin | 1 | 2007 | 164 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 485 | 0.070 |
Why?
|
| Neomycin | 1 | 2004 | 5 | 0.070 |
Why?
|
| Maleimides | 1 | 2004 | 12 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 39 | 0.070 |
Why?
|
| Culture Media, Serum-Free | 1 | 2004 | 40 | 0.070 |
Why?
|
| Cations | 1 | 2004 | 44 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 220 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 72 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 9 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2004 | 170 | 0.060 |
Why?
|
| Carbazoles | 1 | 2004 | 43 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 121 | 0.060 |
Why?
|
| Laminin | 2 | 2014 | 59 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2014 | 46 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 122 | 0.060 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2023 | 37 | 0.060 |
Why?
|
| Indoles | 1 | 2004 | 154 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 522 | 0.060 |
Why?
|
| Middle Aged | 1 | 2017 | 9642 | 0.060 |
Why?
|
| Plasminogen | 2 | 2013 | 10 | 0.060 |
Why?
|
| Fertility | 1 | 2023 | 59 | 0.060 |
Why?
|
| Semen | 1 | 2023 | 48 | 0.060 |
Why?
|
| Faculty | 1 | 2023 | 82 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 580 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 4 | 0.050 |
Why?
|
| Chloroquine | 1 | 2002 | 19 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 45 | 0.050 |
Why?
|
| Testis | 1 | 2023 | 185 | 0.050 |
Why?
|
| Calpain | 1 | 2002 | 31 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 57 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 322 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2023 | 154 | 0.050 |
Why?
|
| Peptides | 2 | 1997 | 308 | 0.050 |
Why?
|
| Mucin-6 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 109 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 200 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 99 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 338 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 88 | 0.050 |
Why?
|
| Mutation | 1 | 2004 | 1023 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2018 | 33 | 0.040 |
Why?
|
| Nordefrin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Students | 1 | 2023 | 452 | 0.040 |
Why?
|
| Leupeptins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 32 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 22 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 46 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 52 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 40 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 52 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 54 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 34 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 1 | 1997 | 7 | 0.040 |
Why?
|
| Autoradiography | 1 | 1997 | 36 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1997 | 51 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 894 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1997 | 22 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 210 | 0.040 |
Why?
|
| Methionine | 1 | 1997 | 28 | 0.040 |
Why?
|
| Culture Media | 1 | 1997 | 84 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 366 | 0.040 |
Why?
|
| Muramidase | 1 | 2017 | 18 | 0.040 |
Why?
|
| Hydroxylation | 1 | 1997 | 14 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 18 | 0.040 |
Why?
|
| Ligands | 1 | 2018 | 317 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 240 | 0.040 |
Why?
|
| Light | 1 | 2018 | 180 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 286 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 151 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 211 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 115 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 161 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2016 | 323 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 34 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 65 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 135 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2013 | 103 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 600 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 89 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 88 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 91 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 75 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 162 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2012 | 8 | 0.030 |
Why?
|
| Annexins | 1 | 2011 | 7 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2011 | 7 | 0.030 |
Why?
|
| Centrosome | 1 | 2012 | 28 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 22 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1300 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 391 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 181 | 0.030 |
Why?
|
| Biological Transport | 1 | 2011 | 175 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 148 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2010 | 13 | 0.020 |
Why?
|
| Onchocerciasis | 1 | 1990 | 6 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 33 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 39 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 309 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 161 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 392 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1990 | 100 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 6448 | 0.020 |
Why?
|
| Skin | 1 | 1990 | 173 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 834 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 642 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 608 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 897 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 413 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 82 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2007 | 175 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 237 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 269 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 310 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 350 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1530 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 932 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2007 | 436 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2003 | 20 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 49 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 88 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 249 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 121 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 383 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 193 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 597 | 0.010 |
Why?
|